Incyte | INCY - هزینه PE به سود

قیمت سهام
94.30
تغییر روزانه
0.18 0.19%
ماهیانه
-5.74%
سالیانه
51.29%
Q2 پیش بینی
87.59




Pe تغییر دادن تاریخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Eli Lilly 40.21 9.66 2025-12
Exelixis 602.31 586.25 2025-12
Gilead Sciences 15.63 0.08 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.85 2.11 2025-12
Novartis 17.79 1.74 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Vertex Pharmaceuticals 26.15 2.22 2025-12